The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent active ingredients / active ingredient combinations within the framework of a cross-active ingredient open-house process, which are prescribed and dispensed at the expense of the health insurance companies in Berlin in the SSB. As a rule, several active ingredients for the same indication are grouped together in 15 specialist groups. Further details can be found in Appendix 11 to the request for quotation. Contrast media of each future contract partner can be ordered for a specialist group during the contract period due to the economic efficiency requirement by the contract physicians, who are informed about these economic sources of supply; they are considered economical. Contract doctors are obliged to meet their need for contrast media from a specialist group with the products of the contract partner or one of the contract partners.
Section A- Designation: Ionic iodine-containing highly osmolar, water-soluble nephrotropic X-ray contrast media.
- Use: oral and / or rectal. More possible
- Application areas:
—— X-ray diagnostics of the gastrointestinal tract, especially if the use of barium sulfate is undesirable or contraindicated and / or
—— for X-ray imaging of the large intestine and / or
—— for examining or delimiting the gastrointestinal tract in computer tomography.
- Dosage form: all approved dosage forms of an active ingredient must be offered
- Concentration: all concentrations of an active ingredient must be offered.
- Package size: all approved package sizes of an active substance must be offered.
- Special feature: The areas of application can also be covered with several products from one provider.
- Further information can be found in Appendix 11 to the request for quotation.
Section N- Designation: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion,
- Use: intravenous. More possible
- Application areas:
- MRI of the liver,
- NSF risk: medium NSF risk,
- Dosage form: all approved dosage forms of an active ingredient,
- Concentration: all concentrations possible,
- Pack size: all approved pack sizes of the active substance.
Further information can be found in Appendix 11 to the request for quotation.
Section O- Designation: Paramagnetic combined extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50),
- Use: intravenous use. More possible
- Application areas:
- MRI of the liver,
- NSF risk: medium NSF risk class,
- Dosage form: all dosage forms of the active ingredient,
- Concentration: all concentrations possible,
- Pack size: all pack sizes of the active substance.
Further information can be found in Appendix 11 to the request for quotation.
Section P- Designation: Contrast media containing barium sulphate,
- Use: Oral and / or intestinal and / or rectal use,
- Application areas,
—— Representation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, others possible,
- Dosage form: all dosage forms of the active ingredient,
- Concentrations: all concentrations possible,
- Pack size: all pack sizes of the active substance.
Further information can be found in Appendix 11 to the request for quotation.
Section Q- Designation: ultrasound contrast medium,
- Use: intravenous use,
- Areas of application: echocardiography, others possible,
- Active ingredients / combinations (ATC): phospholipid microspheres, containing perflutren (V08DA04),
- Dosage form: all dosage forms,
- Concentration: all concentrations possible,
- Package size: all package sizes.
Further information can be found in Appendix 11 to the request for quotation.
Section R- Designation: ultrasound contrast medium,
- Use: intravenous use,
- Areas of application: echocardiography, others possible,
- Active ingredients / combinations (ATC): Albumin microspheres, containing perfluoride (V08DA01),
- Dosage form: all dosage forms,
- Concentration: all concentrations,
- Package size: all package sizes.
Further information can be found in Appendix 11 to the request for quotation.
Section S- Designation: ultrasound contrast medium,
- Use: intravenous use,
- Areas of application: echocardiography, Doppler sonography of the liver and breast, ultrasound of the lower urinary tract,
- Active ingredients / combinations (ATC): sulfur hexafluoride (V08DA05),
- Dosage form: all dosage forms,
- Concentration: all concentrations,
- Package size: all package sizes.
Further information can be found in Appendix 11 to the request for quotation.
Section B- Designation: Ionic iodine-containing highly osmolar, water-soluble nephrotropic X-ray contrast media,
- Application: instillation. More possible
- Application areas:
- retrograde urography,
- micturition cystouretrography,
- Dosage form: all approved dosage forms of an active ingredient must be offered,
- Concentration: all concentrations of an active ingredient must be offered,
- Package size: all approved package sizes of an active substance must be offered.
Further information can be found in Appendix 11 to the request for quotation.
Section C- Designation: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media,
- Use: intra-arterial and intravenous. More possible
- Application areas,
- urography,
- venography, arteriography, angiography,
- angiocardiography,
—— digital subtraction angiography,
—— CT contrast enhancement,
- Dosage form: all approved dosage forms of an active ingredient must be offered,
- Concentrations: must be offered cumulatively,
1. 300 mg / ml-320 mg / ml,
2. 350 mg / ml-400 mg / ml (all concentrations of an active ingredient must be offered, at least all areas of application must be covered),
- Package size: all approved package sizes of an active substance must be offered.
Further information can be found in Appendix 11 of the request for offer.
Section E- Designation: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media,
- Application: intrathecal. More possible
- Application areas:
- cervical, thoracic and lumbar myelography and radiculography,
- CT myelography,
- Dosage form: all approved dosage forms of an active ingredient must be offered,
- concentration:
- 200 mg / ml-300 mg / ml (all concentrations of an active ingredient must be offered),
- Package size: all approved package sizes of an active substance must be offered.
Further information can be found in Appendix 11 to the request for quotation.
Section G- Designation: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media,
- Application: intra-arterial and intravenous and intracavity. More possible
- Application areas:
- urography,
- phlebography,
—— CT contrast enhancement,
—— digital subtraction angiography,
- Dosage form: all approved dosage forms of an active ingredient must be offered,
- Concentration: 150 mg / ml-250 mg / ml, all concentrations of an active ingredient must be offered,
- Package size: all approved package sizes of an active substance must be offered.
Further information can be found in Appendix 11 to the request for quotation.
Section H- Designation: Non-ionic iodine-containing dimeric, low-osmolar, water-soluble nephrotropic X-ray contrast media,
- Use: intra-arterial and intravenous. More possible
- Application areas:
- Cerebral angiography, abdominal angiography, peripheral arteriography, venography,
- urography,
- Contrast enhancement in computed tomography (CT)
Concentrations: must be offered cumulatively:
1) 270 mg / ml,
2) 320 mg / ml.
(all concentrations of an active ingredient must be offered, at least all areas of application must be covered)
Pack size: all approved pack sizes of an active substance must be offered.
Further information can be found in Appendix 11 to the request for quotation.
Section J- Designation: Paramagnetic extracellular linear contrast media for MRI,
- Application: intra-articular application,
- Application areas:
- direct magnetic resonance arthrography,
- NSF risk: high NSF risk class,
- Dosage form: all dosage forms of the active ingredient for this indication,
- Concentration: 0.002 mmol / ml.
- Pack size: all pack sizes of the active ingredient for this indication.
Further information can be found in Appendix 11 to the request for quotation.
Section K- Designation: Paramagnetic extracellular macrocyclic contrast media for MRI,
- Use: intravenous. More possible
- NSF risk: low NSF risk,
- Application areas:
—— Cranial and spinal magnetic resonance tomography,
- MRI of other organs,
- Dosage form: all approved dosage forms of an active ingredient must be offered,
- Concentration: all concentrations of an active ingredient must be offered,
- Package size: all approved package sizes of an active substance must be offered.
Further information can be found in Appendix 11 to the request for quotation.
Section M- Designation: Paramagnetic extracellular macrocyclic contrast media for MRI,
- Application: intra-articular application,
- Areas of application: direct magnetic resonance arthrography,
- NSF risk: low NSF risk class,
- Dosage form: all dosage forms of the active ingredient for this indication,
- concentration: 0.0025 mmol / ml,
- Pack size: all pack sizes of the active ingredient for this indication.
Further information can be found in Appendix 11 to the request for quotation.